Both CSF Aβ42/Aβ40 and pTau181/Aβ42 are markers specific to AD, with the latter biomarker incorporating both amyloid and pTau pathology, while NfL is a marker of axonal degeneration. This evidence concerns the gene NEFL and Alzheimer disease.